Group 3 late-embryogenesis abundant (LEA) protein targeted to the mitochondrial matrix in the anhydrobiotic tardigrade Ramazzottius varieornatus. RvLEAM contains 9 LEA 11-mer repeat motifs predicted to form amphipathic helices under water-deficient conditions; by analogy with other group 3 LEA proteins it is thought to act as a molecular shield against protein aggregation and lipid-membrane damage, although anti-aggregation activity has not been tested for RvLEAM itself. A predicted 31-residue mitochondrial transit peptide directs the protein to the mitochondrial matrix. Heterologous expression in human cells improves osmotic tolerance, consistent with a protective role during desiccation stress. RvLEAM belongs to the LEA type 4 family, which is broadly conserved across plants, nematodes, and other anhydrobiotic organisms.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0005739 mitochondrion | IEA GO_REF:0000044 | MODIFY | Summary: Mitochondrial localization is strongly supported by multiple lines of evidence in PMID:25675104. Immunohistochemistry confirmed mitochondrial localization in tardigrade cells, and RvLEAM-GFP co-localized with MitoTracker Red in human cells. The IEA annotation to the broad term 'mitochondrion' could be refined to 'mitochondrial matrix' (GO:0005759) given that the protein is highly hydrophilic (GRAVY score -0.94, no hydrophobic regions), which strongly suggests matrix rather than membrane localization (PMID:25675104). UniProt annotates a mitochondrial transit peptide at residues 1-31. Reason: The annotation to GO:0005739 (mitochondrion) is correct but insufficiently specific. RvLEAM has a predicted mitochondrial transit peptide (residues 1-31) and is highly hydrophilic with no hydrophobic regions, strongly suggesting localization in the mitochondrial matrix rather than the membrane. The more specific term GO:0005759 (mitochondrial matrix) is warranted based on both the experimental localization data and biophysical properties of the protein. Proposed replacements: mitochondrial matrix Supporting Evidence: PMID:25675104 RvLEAM is a group3 LEA protein and immunohistochemistry confirmed its mitochondrial localization in tardigrade cells PMID:25675104 we identified two novel mitochondrial heat-soluble proteins, RvLEAM and MAHS (Mitochondrial Abundant Heat Soluble), as potent mitochondrial protectants from Ramazzottius varieornatus |
| GO:0009269 response to desiccation | IDA PMID:25675104 Novel mitochondria-targeted heat-soluble proteins identified... | NEW | Summary: RvLEAM is a group 3 LEA protein identified from the anhydrobiotic tardigrade R. varieornatus (PMID:25675104). LEA proteins are well-established components of the desiccation tolerance response in plants, nematodes, and other anhydrobiotic organisms. The protein is described as having protective roles in water-deficient environments, and its expression improves hyperosmotic tolerance of human cells. UniProt annotates this protein with the keyword "Stress response" and describes it as acting as a molecular shield in water-deficient conditions. Reason: This is a core biological process annotation that is missing from GOA. RvLEAM is a LEA protein involved in desiccation tolerance, and its expression improves tolerance to water-deficient conditions. The response to desiccation annotation captures the primary biological context of this protein. Supporting Evidence: PMID:25675104 Late Embryogenesis Abundant (LEA) proteins are heat-soluble proteins involved in the desiccation tolerance of many anhydrobiotic organisms PMID:25675104 tardigrade mitochondria contain at least two types of heat-soluble proteins that might have protective roles in water-deficient environments |
| GO:0006970 response to osmotic stress | IDA PMID:25675104 Novel mitochondria-targeted heat-soluble proteins identified... | NEW | Summary: Tanaka et al. (PMID:25675104) directly demonstrated that expression of RvLEAM improved hyperosmotic tolerance of human HEp-2 cells. This provides direct experimental evidence for a role in response to osmotic stress. Reason: Direct experimental evidence from PMID:25675104 supports this annotation. RvLEAM expression improved hyperosmotic tolerance in human cells, demonstrating the protein functions in the cellular response to osmotic stress. This is the most directly tested biological process for this protein. Supporting Evidence: PMID:25675104 we demonstrated that RvLEAM protein as well as MAHS protein improved the hyperosmotic tolerance of human cells file:RAMVA/RvLEAM/RvLEAM-deep-research-falcon.md Heterologous expression in human HEp-2 cells significantly improves hyperosmotic tolerance |
Loading supporting content…
Download this section (compressed HTML)Q: Does RvLEAM actually bind unfolded or aggregation-prone mitochondrial client proteins in vitro and in cells, and is the predicted amphipathic helical conformation under water-deficient conditions required for that activity? Direct binding has not yet been demonstrated for RvLEAM.
Q: Does RvLEAM also stabilize mitochondrial membranes during desiccation (e.g. preventing inner-membrane fusion or cardiolipin clustering), and does it act synergistically with the cytosolic and mitochondrial CAHS / MAHS proteins?
Q: What is the in vivo consequence of RvLEAM loss-of-function in R. varieornatus - specifically, does loss compromise mitochondrial morphology/function during anhydrobiosis, or is it buffered by the paralogous MAHS and other mitochondrial protectants?
Experiment: Express and purify recombinant RvLEAM (and a transit-peptide-cleaved mature form) and test (i) anti-aggregation activity on representative mitochondrial matrix clients (e.g. citrate synthase, MDH) by light scattering during heat- and desiccation-induced aggregation; and (ii) protection of model mitochondrial-membrane liposomes (cardiolipin / PC bilayers) from drying-induced fusion. Use circular dichroism to confirm disorder-to-amphipathic-helix transitions under low-water conditions.
Hypothesis: Purified RvLEAM prevents aggregation of mitochondrial matrix clients and stabilizes cardiolipin-containing liposomes during desiccation, and these activities track its disorder-to-helix transition.
Type: in vitro biochemical and biophysical assay
Experiment: Generate a CRISPR knockout (or RNAi knockdown) of RvLEAM in R. varieornatus, alone and in combination with MAHS, and assay anhydrobiosis survival, mitochondrial respiration, and ultrastructure (EM) before / during / after desiccation-rehydration cycles.
Hypothesis: Loss of RvLEAM compromises mitochondrial integrity and reduces survival of desiccation in vivo, with stronger phenotypes when MAHS is also knocked out.
Type: in vivo loss-of-function phenotyping
Experiment: In human HEK293 / HEp-2 cells, target RvLEAM to the mitochondrial matrix using a defined mitochondrial transit peptide and quantify protection of mitochondrial respiration, membrane potential, and oxidative phosphorylation efficiency under hyperosmotic, oxidative, and drying-rehydration stress, including a transit-peptide-deleted (cytosolic) control.
Hypothesis: Mitochondrial matrix localization is required for RvLEAM's protective activity in human cells; mis-localized cytosolic RvLEAM provides little or no protection against mitochondrial dysfunction under stress.
Type: heterologous expression with subcellular targeting controls
Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)